The FDA grants 510(k) clearance for Luminex’s (NASDAQ:LMNX)
ARIES MRSA Assay, an integrated, in vitro diagnostic test for the
direct detection of methicillin-resistant Staphylococcus aureus (MRSA)
DNA from nasal swabs in patients at risk for nasal colonization.
The Luminex ARIES System is a sample to answer,
real-time instrument designed to increase laboratory efficiency and
ensure result accuracy.
https://seekingalpha.com/news/3502870-fda-clears-luminexs-aries-mrsa-assay
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.